PMID: 7514585Mar 1, 1994Paper

Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells

Japanese Journal of Cancer Research : Gann
H NishidaY Muto

Abstract

The inhibitory effect of (-)-epigallocatechin gallate (EGCG), a main constituent of Japanese green tea, on spontaneous hepatoma in C3H/HeNCrj mice was investigated. A total of 72 mice were divided into three groups; the control group without EGCG, and two experimental groups receiving 0.05% (w/w) or 0.1% EGCG in drinking water. EGCG reduced the incidence of hepatoma-bearing mice from 83.3% (control) to 56.0% (0.05% EGCG) and 52.2% (0.1% EGCG), and also reduced the average number of hepatomas per mouse from 1.83 (control) to 0.72 (0.05% EGCG) and 0.91 (0.1% EGCG) at week 65. Ridit analysis of the distribution of the number of hepatomas in each group revealed that EGCG significantly increased the rate of mice without hepatoma in the two EGCG groups as compared to the control. EGCG did not affect body weight gain, food consumption or any serum biochemical parameter. EGCG inhibited the growth and secretion of alpha-fetoprotein by human hepatoma-derived PLC/PRF/5 cells without decreasing their viability. These results indicate that EGCG may be a practical, nontoxic preventive agent against human hepatoma.

References

May 1, 1992·Preventive Medicine·H MukhtarR Agarwal
May 1, 1992·Preventive Medicine·H HayatsuI Sakata
Nov 1, 1991·Japanese Journal of Cancer Research : Gann·O YamauchiY Muto
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A BuchmannM Schwarz
Oct 1, 1988·Japanese Journal of Cancer Research : Gann·S KonoM Kuratsune

❮ Previous
Next ❯

Citations

Oct 8, 1999·European Journal of Drug Metabolism and Pharmacokinetics·C NepkaD Kouretas
Oct 1, 1994·Clinical Biochemistry·B Stavric
Jan 26, 2002·Journal of Photochemistry and Photobiology. B, Biology·S K KatiyarC A Elmets
Jan 8, 1999·Mutation Research·Y Kuroda, Y Hara
Jun 16, 2012·Journal of Cancer Research and Clinical Oncology·Hirota FujikiMasami Suganuma
Mar 20, 2015·International Journal of Molecular Sciences·Masahito ShimizuHisataka Moriwaki
Jan 3, 2006·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R A IsbruckerJ Bausch
Apr 24, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Dimitrios StagosDimitrios Kouretas
May 26, 1998·Japanese Journal of Cancer Research : Gann·K NakachiY Higashi
Jul 1, 1997·Japanese Journal of Cancer Research : Gann·S OkabeH Fujiki
Oct 1, 1996·Japanese Journal of Cancer Research : Gann·N MatsumotoY Hara
Jul 6, 2017·Critical Reviews in Food Science and Nutrition·Kwan-Wai NgTao Yi
Jul 10, 2003·International Journal of Toxicology·Robert R SwezeyCarol E Green
Dec 25, 2007·Antioxidants & Redox Signaling·Naghma KhanHasan Mukhtar
Mar 10, 2001·BioFactors·M IsemuraM Sazuka
Sep 2, 2009·Biological & Pharmaceutical Bulletin·Yasuyuki SadzukaTakashi Sonobe
Dec 17, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Christopher D MannDavid P Berry
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K M PistersJ S Lee
Apr 14, 2011·Fukushima Journal of Medical Science·Yoshihisa TakahashiToshio Fukusato
Nov 1, 1996·Nutrition Reviews·H FujikiY Sakai
Apr 24, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Estefanny Ruiz GarcíaReggiani Vilela Gonçalves

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.